Cargando…
Analysis of Hepatic Artery Infusion (HAI) Chemotherapy Using Randomized Trials of Floxuridine (FUDR) for Colon Cancer Patients with Multiple Liver Metastases
Colorectal cancer (CRC) is one of the leading causes of cancer-related death, with most of the people who have the disease developing numerous liver metastases. Sixty percent of colon cancer patients have liver metastases. Only 25% of those with resectable hepatic metastases are alive, and recurrenc...
Autor principal: | Li, Yuanming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068314/ https://www.ncbi.nlm.nih.gov/pubmed/35529034 http://dx.doi.org/10.1155/2022/3546455 |
Ejemplares similares
-
Retracted: Analysis of Hepatic Artery Infusion (HAI) Chemotherapy Using Randomized Trials of Floxuridine (FUDR) for Colon Cancer Patients with Multiple Liver Metastases
por: Research and Practice, Gastroenterology
Publicado: (2023) -
The Effects on Liver Metastases of Circadian Patterned Continuous Hepatic Artery Infusion of FUDR
por: Kemeny, M. Margaret, et al.
Publicado: (1994) -
Treatment interruptions and complications with two continuous hepatic artery floxuridine infusion systems in colorectal liver metastases.
por: Fordy, C., et al.
Publicado: (1995) -
Hepatic arterial floxuridine as second-line treatment for systemic fluorouracil-resistant colorectal liver metastases.
por: Fordy, C., et al.
Publicado: (1998) -
Hepatic Artery Infusion of Floxuridine in Combination With Systemic Chemotherapy for Pancreatic Cancer Liver Metastasis: A Propensity Score-Matched Analysis in Two Centers
por: Peng, Changli, et al.
Publicado: (2021)